MedElevator Войти в исследования
← Поиск публикаций

DOI 10.46989/001c.161719

Медицинская библиотека · Clinical hematology international · 2026

Allogeneic hematopoietic stem cell transplantation for VEXAS syndrome: A review and a case report.

Nagae Kentaro, Muranushi Hiroyuki, Nannya Yasuhito, Maeda Takeshi

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND

VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is caused by somatic UBA1 mutations and frequently complicated by myelodysplastic syndrome (MDS). Conventional immunosuppressive and anti-inflammatory therapies are often ineffective, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) is currently the only curative treatment, although its optimal timing and donor selection remain uncertain.

CASE PRESENTATION: A 67-year-old man with VEXAS syndrome and MDS harboring UBA1 (p.M41T) and EZH2 mutations, refractory to azacitidine and corticosteroids, successfully underwent allo-HSCT from a one-antigen-mismatched related donor. Post-transplant chronic graft-versus-host disease was well controlled with ruxolitinib.

METHODS AND

RESULTS

We reviewed eight studies comprising 45 allo-HSCT recipients with VEXAS syndrome. The median age at transplantation was 59 years, and patients had received a median of five prior systemic therapies. MDS was present in 53.3% of cases, while 42.2% underwent transplantation for VEXAS without overt hematologic malignancy. The most frequent UBA1 variant was p.Met41Val (37.8%). At last follow-up, 84.4% of patients were alive, with resolution of inflammatory manifestations in most cases.

CONCLUSION

Allo-HSCT represents a curative option for refractory VEXAS syndrome. Comprehensive genetic profiling may aid in identifying candidates for early transplantation. If early transplantation is required, human leukocyte antigen-mismatched donors may be selected.

Для цитирования: Nagae Kentaro, Muranushi Hiroyuki, Nannya Yasuhito, Maeda Takeshi. Allogeneic hematopoietic stem cell transplantation for VEXAS syndrome: A review and a case report.. Clinical hematology international. 2026. DOI: 10.46989/001c.161719.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.